http://www.igenericdrugs.com Review Rating: 100 out of 100 based on 473 reviews. 473 stars
Generic drugs
List of interchangeable brand and generic drugs
compare generic drug prices
 

Cefurol

Search a suitable generic or branded drugs, if you could not find the prescribed medicine. This site does not supply any medicines. It contains prices for information purposes only. You should consult a doctor about the dosage before using this medicine!

DRUG NAME:     

 

Cefurol uses and description

Sort by popularity
Cefurol - Pharmacology: Inhibits mucopeptide synthesis in bacterial cell wall.

Indication: Oral form

Treatment of infections of lower respiratory tract, urinary tract, skin and skin structures; treatment of uncomplicated gonorrhea, otitis media, pharyngitis, and tonsillitis caused by susceptible strains of specific microorganisms. Treatment of early Lyme disease, pharyngitis/tonsillitis, and impetigo.

Parenteral form

Treatment of infections of lower respiratory tract, urinary tract, skin and skin structures, bone and joint; preoperative prophylaxis; treatment of septicemia, gonorrhea, and meningitis caused by susceptible strains of specific microorganisms.

Cefurol is in a group of drugs called cephalosporin (SEF a low spor in) antibiotics. It works by fighting bacteria in your body.

Cefurol is used to treat many kinds of bacterial infections, including severe or life-threatening forms.

Cefurol may also be used for other purposes not listed in this medication guide.

Cefurol is a β-lactam type antibiotic. More specifically, it is a second-generation cephalosporin. Cephalosporins work the same way as penicillins: they interfere with the peptidoglycan synthesis of the bacterial wall by inhibiting the final transpeptidation needed for the cross-links. This effect is bactericidal. Cefurol is effective against the following organisms: Aerobic Gram-positive Microorganisms: Staphylococcus aureus, Streptococcus pneumoniae, Streptococcus pyogenes. Aerobic Gram-negative Microorganisms: Escherichia coli, Haemophilus influenzae (including beta-lactamase-producing strains), Haemophilus parainfluenzae, Klebsiella pneumoniae, Moraxella catarrhalis (including beta-lactamase-producing strains), Neisseria gonorrhoeae (including beta-lactamase-producing strains). Spirochetes: Borrelia burgdorferi. Cefurol axetil is the prodrug

Cefurol is an antibiotic. It is used to treat certain bacterial infections of the nose, throat, chest, ears, skin, bladder, bones, joints and brain. Cefurol is also used to treat a sexually-transmitted disease known as gonorrhoea. Cefurol belongs to a group of antibiotics called the cephalosporins.

Oral Uncomplicated urinary tract infections

Adult: 125 mg bid. Oral Respiratory tract infections

Adult: 250-500 mg bid.

Child: >3 mth: 125 mg bid or 10 mg/kg bid. Max dose: 250 mg daily. Oral Uncomplicated gonorrhoea

Adult: 1 g as a single dose. 1 g oral probenecid may be given concurrently. Oral Otitis media

Child: >2 yr: 250 mg bid or 15 mg/kg bid up to 500 mg daily. Intravenous Meningitis

Adult: 3 g every 8 hr.

Child: 200-240 mg/kg/day in 3-4 divided doses, decreased to 100 mg/kg/day after 3 days or once symptoms have improved. Neonate: 100 mg/kg/day, decreased to 50 mg/kg/day when control has been achieved. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Intramuscular Gonorrhoea

Adult: 1.5 mg as a single dose divided between 2 inj sites. 1 g oral probenecid may be given concurrently. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Prophylaxis of surgical infections

Adult: 1.5 g IV before the procedure followed by 750 mg IM every 8 hr for up to 24-48 hr depending on the procedure. For total joint replacement, 1.5 g of Cefurol may be mixed with methylmethacrylate cement. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Susceptible infections

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Incompatibility: Incompatible with aminoglycosides.

Oral Uncomplicated urinary tract infections

Adult: 125 mg bid. Oral Respiratory tract infections

Adult: 250-500 mg bid.

Child: >3 mth: 125 mg bid or 10 mg/kg bid. Max dose: 250 mg daily. Oral Uncomplicated gonorrhoea

Adult: 1 g as a single dose. 1 g oral probenecid may be given concurrently. Oral Otitis media

Child: >2 yr: 250 mg bid or 15 mg/kg bid up to 500 mg daily. Intravenous Meningitis due to sensitive strains of bacteria

Adult: 3 g every 8 hr.

Child: 200-240 mg/kg/day in 3-4 divided doses, decreased to 100 mg/kg/day after 3 days or once symptoms have improved. Neonate: 100 mg/kg/day, decreased to 50 mg/kg/day when control has been achieved. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Intramuscular Gonorrhoea

Adult: 1.5 mg as a single dose divided between 2 inj sites. 1 g oral probenecid may be given concurrently. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Prophylaxis for surgical infection

Adult: 1.5 g IV before the procedure followed by 750 mg IM every 8 hr for up to 24-48 hr depending on the procedure. For total joint replacement, 1.5 g of Cefurol may be mixed with methylmethacrylate cement. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Bone and joint infections

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Gonorrhoea

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Lower respiratory tract infections

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Meningitis

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Otitis media

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral UTI

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Peritonitis

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Pharyngitis

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Sinusitis

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Parenteral Skin and soft tissue infections

Adult: 750 mg every 8 hr given as deep IM or slow IV inj over 3-5 min or IV infusion, increased to 1.5 g every 6-8 hr in severe infections.

Child: 30-60 mg/kg/day, may increase to 100 mg/kg/day if necessary. To be given in 3-4 divided doses or 2-3 divided doses in neonates. Renal impairment: Patients undergoing haemodialysis should receive an additional 750-mg dose after each dialysis; those undergoing continuous peritoneal dialysis may be given 750 mg bid. CrCl (ml/min) Dosage Recommendation 10-20 750 mg bid. <10 750 mg once daily. Incompatibility: Incompatible with aminoglycosides.

Indications:

Adult: PO Uncomplicated UTI 125 mg twice daily. Resp tract infections 250-500 mg twice daily. Uncomplicated gonorrhoea W/ oral probenecid: 1 g as a single dose. IV Meningitis 3 g 8 hrly. IM Gonorrhoea W/ oral probenecid: 1.5 g as a single dose. IV/IM Surgical prophylaxis 1.5 g IV per-op, then 750 mg IM 8 hrly for up to 24-48 hr. Susceptible infections 750 mg 8 hrly, up to 1.5 g 6-8 hrly for severe infections.

Indications: Respiratory tract infections.

Uncomplicated gonorrhoea.

Otitis media.

Meningitis, Prophylaxis of surgical infections.

Susceptible infections.

Active ingredients: Cefuroxime
Unit description, dosagePrice, USD

List of cefurol brand and generic drugs

Cefuroksim (Serbia)
Injectable; Subcutaneous; Cefuroxime Sodium 1.5 g
Cefuromek (Peru)
Cefuron (Peru)
Cefuron 250 mg Tablet$ 0.60
Cefuron 500 mg Tablet$ 1.15
Cefuronat
Cefuronat 500 mg Tablet$ 0.83
Cefuronat 125 mg Tablet$ 0.28
Cefuronat 250 mg Tablet$ 0.46
Cefuroprol (Greece)
Cefurox (Argentina)
Tablet, Film-Coated; Oral; Cefuroxime 250 mg
Tablet, Film-Coated; Oral; Cefuroxime 500 mg
Cefurox 125 mg x 14's
Cefurox 250 mg x 14's
Cefurox 500 mg x 14's
Cefurox 125 mg/5 mL x 50 mL
Cefurox 125 mg/5 mL x 70 mL
Cefurox 250 mg/5 mL x 50 mL
Cefurox 250 mg x 1 Blister x 10 Tablet
Cefurox 500 mg x 1 Blister x 10 Tablet
Cefurox 500 mg allied chemicals Tablet$ 0.36
Cefurox 500 mg Tablet$ 1.36
Cefurox 250 mg Tablet$ 0.46
Cefurox 125
Cefurox 250
Cefurox 750
Cefurox Basics (Germany)
Cefurox-Reu
Cefurox-Wolff (Germany)
Cefuroxim (Netherlands, Norway)
Injectable; Subcutaneous; Cefuroxime Sodium 1.5 g
Injectable; Subcutaneous; Cefuroxime 1500 mg
Injectable; Subcutaneous; Cefuroxime Sodium 750 mg
Tablet, Film-Coated; Oral; Cefuroxime Sodium 125 mg
Tablet, Film-Coated; Oral; Cefuroxime Sodium 250 mg
Tablet, Film-Coated; Oral; Cefuroxime Sodium 500 mg
Powder for Suspension; Oral; Cefuroxime
Tablet, Film-Coated; Oral; Cefuroxime 250 mg
Tablet, Film-Coated; Oral; Cefuroxime 500 mg
Injectable; Subcutaneous; Cefuroxime 250 mg
Injectable; Subcutaneous; Cefuroxime 750 mg
Cefuroxim - 1 A Pharma (Germany)
Cefuroxim Actavis (Switzerland)
Cefuroxim AL (Germany)
Cefuroxim Aristo (Germany)
Cefuroxim Aristo 250 mg x 10 ho├Ąp x 1 Blister x 4 Tablet

Show all Cefurol generic names
 
Privacy Policy
© 2003 - 2014 igenericdrugs.com All Rights Reserved
 
Disclamer